COMMUNIQUÉS West-GlobeNewswire

Summit Therapeutics Announces Placement of £15.0 Million of Ordinary Shares
27/03/2018
OXFORD, United Kingdom, March 27, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ: SMMT ) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and C. [...]
Prospectus relating to Active Biotech's rights issue published
27/03/2018
2018-03-27 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN OR CANADA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OF THIS PRESS RELEASE WOULD [...]
Summit Therapeutics Announces a Proposed Placing to Raise up to £15 Million
27/03/2018
THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION WHERE TO DO SO MIGHT [...]
Tecan publishes 2017 Annual Report and notice of its Annual General Meeting
27/03/2018
Männedorf, Switzerland, March 27, 2018 - The Tecan Group (SIX Swiss Exchange: TECN) today announced the publication of its 2017 Annual Report in the Investor Relations section of the company's website at www.tecan.com [...]
Novartis to sell stake in consumer healthcare joint venture to GSK for USD13.0 billion to focus on strategic priorities
27/03/2018
Price reflects an attractive value to Novartis Proceeds to be used according to capital allocation priorities, including bolt-on acquisitions Sale of JV in a non-core segment in best long-term interests of Novartis [...]
Probiodrug AG to Publish its Full Year 2017 Results on 3 April 2018
27/03/2018
Probiodrug AG to Publish its Full Year 2017 Results on 3 April 2018 HALLE (SAALE), Germany, 27 March 2018 - Probiodrug AG (Euronext Amsterdam: PBD), a clinical stage biopharmaceutical company developing novel [...]
VIFOR PHARMA CONCLUDES LICENSING AGREEMENT WITH ZERIA TO MARKET VELTASSA® IN JAPAN
27/03/2018
Vifor Pharma gives Zeria exclusive rights to develop and market Veltassa ® in Japan Potential of Veltassa ® further validated with expansion into Japanese market Deal expands cardio-renal network with Vifor Pharma's [...]
Aslan Pharmaceuticals Files for Proposed Initial Public Offering in the U.S.
27/03/2018
SINGAPORE, March 26, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (ASLAN) (6497.TT), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the [...]
Hua Medicine Raises $117.4 Million in Series D & Series E Financing
27/03/2018
HONG KONG and SHANGHAI, China, March 26, 2018 (GLOBE NEWSWIRE) -- Hua Medicine, a clinical-stage drug development company developing novel therapies for the treatment of Type 2 diabetes, announced the closing of a [...]
BioStem Technologies, Inc. Announces Letter of Intent with CCM Pharma Solutions to Co-Develop Multiple Solid to Liquid Dose Drugs Through 505(b)(2) Accelerated FDA Approval Process
27/03/2018
Pompano Beach, FL, March 26, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a global life sciences corporation providing innovative technologies with a focus in [...]
R1 Appoints Alex Mandl as Lead Director
26/03/2018
Steve Shulman Resigns as Chairman of the Board Bert Zimmerli Appointed as Director CHICAGO, March 26, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (“R1” or the “Company”) (NASDAQ: RCM ), a leading provider of technology-enabled [...]
Matinas BioPharma Reports 2017 Financial Results
26/03/2018
BEDMINSTER, N.J., March 26, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER:MTNB), a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications [...]
Emergent BioSolutions Announces Executive Management Changes That Enhance Execution of Company’s Growth Strategy
26/03/2018
GAITHERSBURG, Md., March 26, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS ) today announced executive management changes that continue to align its organizational structure to its long-term strategy [...]
Intercept to Present at Upcoming Conference
26/03/2018
NEW YORK, March 26, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT ), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]
Quotient Limited Reports Blood Grouping Concordance Data From MosaiQ Verification and Validation Studies and Updates on the Completion of Its Sale Leaseback Transaction
26/03/2018
Verification & Validation (“V&V”) “head-to-head” data exceeds target concordance for blood grouping Overall concordance for antigen typing – 99.8%, demonstrating robustness of the MosaiQ platform Completion of [...]
Eyenovia Appoints Three Industry Veterans to Board of Directors
26/03/2018
NEW YORK, March 26, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN ), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to [...]
AnaptysBio Announces Positive Top-Line Proof-of-Concept Data For ANB020 In Moderate-to-Severe Baseline Adult Peanut Allergy Patients
26/03/2018
46% of adult peanut allergy patients with moderate-to-severe baseline symptoms tolerated 500mg cumulative peanut challenge at 14 days after a single dose of ANB020 compared to zero percent dosed with placebo Concomitant [...]
Quotient Limited Announces Retirement of Paul Cowan, Chairman and Chief Executive Officer; Franz Walt Named as Interim Chief Executive Officer
26/03/2018
JERSEY, Channel Islands, March 26, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT ), a commercial-stage diagnostics company, today announced the retirement of Paul Cowan as its Chairman and Chief Executive [...]
Sol-Gel Technologies Ltd. Availability of Its Annual Report on Form 20-F Through Its Website
26/03/2018
NESS ZIONA, Israel, March 26, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (NASDAQ: SLGL ), a clinical-stage dermatology company, announced today that it filed its Annual Report for 2017 on Form 20-F, containing [...]

Pages